Bevacizumab combination therapy in recurrent, platinum-refractory, epithelial ovarian carcinoma: A retrospective analysis.

Find People
Find Everything
About This Site
Edit My Profile
Login to Profiles
DIRECT2Experts
Help / FAQ

Announcement

You can now add alternative names! Click here to add other names that you've published under.

Bevacizumab combination therapy in recurrent, platinum-refractory, epithelial ovarian carcinoma: A retrospective analysis.

Wright JD, Hagemann A, Rader JS, Viviano D, Gibb RK, Norris L, Mutch DG, Powell MA. Bevacizumab combination therapy in recurrent, platinum-refractory, epithelial ovarian carcinoma: A retrospective analysis. Cancer. 2006 Jul 01; 107(1):83-9.

View in: PubMed

subject areas

Adult
Aged
Angiogenesis Inhibitors
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Cohort Studies
Cyclophosphamide
Deoxycytidine
Doxorubicin
Drug Resistance, Neoplasm
Female
Fluorouracil
Humans
Intestinal Perforation
Middle Aged
Neoplasms, Glandular and Epithelial
Ovarian Neoplasms
Platinum Compounds
Retrospective Studies
Taxoids
Tomography Scanners, X-Ray Computed
Treatment Outcome

authors with profiles

Janet Rader